Literature DB >> 2893702

Disposition, pharmacokinetics, and metabolism of a dermal dose of [14C]2,5-hexanedione in hens.

E Suwita1, A A Nomeir, M B Abou-Donia.   

Abstract

A dermal dose of 50 mg/kg (7.5 microCi/kg) of [14C]2,5-hexanedione (2,5-HD) was applied on a protected area on the backs of hens. Five groups of three hens were killed after 4, 8, 24, 36, and 48 hr. 2,5-HD disappeared monoexponentially from the application site with a half-life of 6 hr. After 48 hr, 35% of the radioactivity was expired as volatile material, largely as 2,5-HD. The combined urinary fecal excreta accounted for 15% of the eliminated radioactivity, while the 14CO2 accounted for 11.9% of the radioactive dose. The highest concentration of 14C was detected in the bile. Among tissues analyzed, liver and kidney contained the highest concentrations of radioactivity, whereas the brain, spinal cord, and peripheral nerves showed smaller concentrations. The half-lives for the elimination of 14C were longest for muscle (71 hr) and shortest for adipose tissue (12 hr), while the remaining tissues showed half-lives ranging from 20 to 30 hr. Radioactivity in the plasma reached a peak at 4 hr. Most of this radioactivity was identified as 5-hydroxy-2-hexanone followed by 2,5-HD and 2,5-dimethylfuran; these chemicals then disappeared biexponentially with terminal half-lives of 7.6 hr, 12.6 hr, and 28.6 hr, respectively. 2,5-HD was the most accounted chemical found in the liver, lung, and kidney, while 5-hydroxy-2-hexanone was found to be most abundant in the combined urinary-fecal excreta.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2893702

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  1 in total

1.  Different administration schedules of the same dose of 2,5-hexanedione influence the development of neuropathy and the toxicokinetics.

Authors:  J Misumi; M Nagano; M Futatsuka; W Zhao; M Kudo
Journal:  Neurochem Res       Date:  1997-01       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.